A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
Public ClinicalTrials.gov record NCT01456052. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Assessment of the Relationship Between Serotonin and Efficacy in Ulcerative Colitis: A Multi-Center Randomized, Double Blind, Placebo-Controlled, Pilot Study to Evaluate Safety and Preliminary Efficacy of Orally Administered LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Study identification
- NCT ID
- NCT01456052
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Lexicon Pharmaceuticals
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- Telotristat Etiprate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 29, 2012
- Primary completion
- Sep 2, 2013
- Completion
- Sep 2, 2013
- Last update posted
- May 22, 2019
2012 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lexicon Investigational Site | Little Rock | Arkansas | 72205 | — |
| Lexicon Investigational Site | Anaheim | California | 92801 | — |
| Lexicon Investigational Site | Santa Monica | California | 90404 | — |
| Lexicon Investigational Site | Great Neck | New York | 11021 | — |
| Lexicon Investigational Site | New York | New York | 10017 | — |
| Lexicon Investigational Site | Tulsa | Oklahoma | 74135 | — |
| Lexicon Investigational Site | Houston | Texas | 77030 | — |
| Lexicon Investigational Site | San Antonio | Texas | 78229 | — |
| Lexicon Investigational Site | Ogden | Utah | 84405 | — |
| Lexicon Investigational Site | Sandy City | Utah | 84094 | — |
| Lexicon Investigational Site | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01456052, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01456052 live on ClinicalTrials.gov.